Marburg virus (MARV) is a member of the filovirus family that causes hemorrhagic disease
with high case fatality rates. MARV is on the priority list of the World Health Organization for …

Marburg virus (MARV) is the causative agent of hemorrhagic fever outbreaks with high case
fatality rates. Closely related to Ebola virus, MARV is a filamentous virus with a negative …

Background Marburg virus (MARV) is the causative agent of Marburg virus disease (MVD)
which has a case fatality rate up to∼ 90% in humans. Recently, there were cases reported …

The filoviruses, Marburg virus (MARV) and Ebola virus, causes severe hemorrhagic fever
with high mortality in humans and nonhuman primates. A promising filovirus vaccine under …

Background Effective countermeasures are urgently needed to prevent and treat infections
caused by highly pathogenic and biological threat agents such as Marburg virus (MARV) …

Marburg virus (MARV) has been associated with sporadic episodes of hemorrhagic fever,
including a recent highly publicized outbreak in Angola that produced severe disease and …

Postexposure immunization can prevent disease and reduce transmission following
pathogen exposure. The rapid immunostimulatory properties of recombinant vesicular …

Background Marburg virus (MARV), an Ebola-like virus, remains an eminent threat to public
health as demonstrated by its high associated mortality rate (23–90%) and recent …

Background Recent deadly outbreaks of Marburg virus underscore the need for an effective
vaccine. A summary of the latest research is needed for this WHO priority pathogen. This …

Vaccines and therapies are urgently needed to address public health needs stemming from
emerging pathogens and biological threat agents such as the filoviruses Ebola virus (EBOV) …